相关实验视频

Updated: Jul 16, 2025

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

在出血性遗传性telangiectasia的新遗传驱动因素

Pau Cerdà¹, Sandra D Castillo², Cinthia Aguilera³

¹HHT Unit, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

European journal of internal medicine

|September 9, 2023

概括

这项研究确定了遗传性出血长管病 (HHT) 的新遗传驱动因素,这是一种罕见的血管疾病. 研究人员在SMAD6等基因中发现了变异,为未知遗传原因的患者提供了新的诊断途径.

科学领域:

遗传学是一个遗传学.
血管生物学血管生物学
罕见疾病罕见疾病

背景情况:

遗传性出血性长膜炎 (HHT) 是一种自体主导的血管疾病.
ENG和ACVRL1基因的突变解释了大多数HHT病例,但8%仍然无法从遗传学上解释.
识别新的遗传驱动因素对于全面的HHT诊断至关重要.

研究的目的:

在未知遗传病因的患者中识别遗传性出血性长膜病变 (HHT) 的新型遗传原因.
为了研究潜在的新基因候选人,涉及到HHT病变发生.

主要方法:

对19名HHT患者及其亲属进行了外体序列测序.
一个多步过策略优先考虑候选基因基于内皮细胞生物学相关性.
对一种已识别的变种进行了体外验证.

主要成果:

在INHA,HIF1A,JAK2,DNM2,POSTN,ANGPTL4,FOXO1和SMAD6的变种被确定为潜在的HT驱动因素.
发现一种功能丧失的SMAD6变体 (p.(Glu407Lys)) 激活了内皮细胞中的BMP/TGFβ信号传递.
这表明这些基因在HHT发育中起作用.

结论:

这些已识别的基因 (INHA,HIF1A,JAK2,DNM2,POSTN,ANGPTL4,FOXO1,SMAD6) 应该在对HHT进行基因检测时考虑.
这将HHT的遗传景观扩展到已知的突变之外.
对这些基因的进一步调查可以改善HHT患者的诊断产量.

关键词:

遗传学是一个遗传学.遗传性出血性远距离切除症 (telangiectasia) 是一种遗传性出血性远距离切除症.氧气过低是因为缺氧.罕见疾病是一种罕见的疾病.在SMAD6中,我们可以看到SMAD6.

更多相关视频

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Genetic Lingo

Genetic Lingo